 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/12/2024 |
$4.46 |
$4.46 |
$4.33 |
$4.33 |
1.40K | | 04/15/2024 |
$4.11 |
$4.32 |
$4.11 |
$4.14 |
9.10K | | 04/16/2024 |
$3.91 |
$4.01 |
$3.82 |
$4.01 |
2.60K | | 04/17/2024 |
$4.30 |
$4.30 |
$3.81 |
$3.86 |
2.80K | | 04/18/2024 |
$3.92 |
$4.39 |
$3.92 |
$4.14 |
7.90K |
|
|
| Xenetic Biosciences is a biopharmaceutical company. Co.'s drug candidates pipeline include: XCART, which is a CAR T cell platform technology engineered to target patient-specific tumor neoantigens; ErepoXen (polysialylated erythropoietin), which uses Co.'s PolyXen platform technology for the treatment of anemia in chronic kidney disease patients; XBIO-101, which is an internal candidate with orphan drug designation from the U.S. Food and Drug Administration for the potential treatment of progesterone receptor negative endometrial cancer in conjunction with progesterone therapy; and OncoHist, which utilizes the properties of modified human histone H1.3 for targeted cell killing. | |
|
Xenetic Biosciences (XBIO) has the following price history information. Looking back at XBIO historical stock prices for the last five trading days, on April 12, 2024, XBIO opened at $4.46, traded as high as $4.46 and as low as $4.33, and closed at $4.33. Trading volume was a total of 1.40K shares. On April 15, 2024, XBIO opened at $4.11, traded as high as $4.32 and as low as $4.11, and closed at $4.14. Trading volume was a total of 9.10K shares. On April 16, 2024, XBIO opened at $3.91, traded as high as $4.01 and as low as $3.82, and closed at $4.01. Trading volume was a total of 2.60K shares. On April 17, 2024, XBIO opened at $4.30, traded as high as $4.30 and as low as $3.81, and closed at $3.86. Trading volume was a total of 2.80K shares. On April 18, 2024, XBIO opened at $3.92, traded as high as $4.39 and as low as $3.92, and closed at $4.14. Trading volume was a total of 7.90K shares.
XBIO Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Xenetic Biosciences shares, starting with a $10,000 purchase of XBIO, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
06/30/2016 |
|
| End date: |
04/18/2024 |
|
| Start price/share: |
$612.00 |
|
| End price/share: |
$4.14 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-99.32% |
|
| Average Annual Total Return: |
-47.27% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$67.69 |
|
| Years: |
7.81 |
|
|
|
| Date |
Close |
| 04/12/2024 | $4.33 | | 04/15/2024 | $4.14 | | 04/16/2024 | $4.01 | | 04/17/2024 | $3.86 | | 04/18/2024 | $4.14 |
|
|
Free XBIO Email Alerts:
